The US Food and Drug Administration (FDA)Wednesday announced the approval of Teva's albuterol sulfate inhalation powder (ProairRespiClick), a breath-actuated, multi-dose, dry-powder, short-acting beta-agonist (SABA) inhaler for treating or preventing bronchospasm in patients 12 years and older suffering from reversible obstructive airway disease and for preventing exercise-induced bronchospasm (EIB) in patients 12 years and older.
Read More
Plaque Psoriasis: Cosentyx Continues to Come Out on Top
March 22nd 2015Novartis announced results from the CLEAR study demonstrating Cosentyxâ„¢ (secukinumab) improved skin clearance at Week 16 in significantly more moderate-to-severe plaque psoriasis patients compared to Stelara®* (ustekinumab), a widely used biologic.
Read More
Benefits Seen for Brain Shield Used with TAVR
March 15th 2015The TriGuard filter, an investigational device designed to protect the brain from hazardous debris released during transcatheter aortic valve replacement (TAVR) and other procedures was found to improve in-hospital safety outcomes and cognitive scores at discharge.
Read More
SAPIEN 3 Improves Outcomes in Intermediate-risk Patients
March 15th 2015Compared with earlier generation devices, the SAPIEN 3 heart valve exhibited lower death, stroke, and paravalvular leak rates in high-risk surgery patients and demonstrated encouraging results in intermediate-risk patients.
Read More
Self-expanding TAVR Preferred Over Surgery
March 15th 2015Self-expanding transcatheter aortic valve replacement (TAVR) in high-risk aortic stenosis patients produces a more consistent survival rate compared with standard surgery, according to 2-year data presented at the American College of Cardiology meeting in San Diego, CA.
Read More
Aged Garlic Extract: Slows CV Risk Factors
March 14th 2015Previous studies have revealed Aged Garlic Extract (AGE) retards multiple cardiovascular risk factors, including blood pressure, cholesterol, platelet aggregation, and adhesion, while triggering nitric oxide generation within endothelial cells.
Read More
PROMISE Trial: CTA or Stress Test?
March 14th 2015The PROMISE Trial (PROspective Multicenter Imaging Study for Evaluation of chest pain) showed no improvement in clinical outcomes when using Anatomic CT over functional testing for screening for coronary artery disease, however it did find an overall increase in radiation exposure.
Read More
BMI Matters: Predicting Cardiovascular Event Risk
March 13th 2015While various epidemiological studies have shown obesity to be linked with inflammation and with increased cardiovascular risk, the inflammatory marker C-reactive protein (CRP) takes it a step further, strongly predicting the incidence of cardiovascular events.
Read More
Obese Patients and Acute Systolic Heart Failure, Latest Findings
March 13th 2015Research has consistently identified obesity as a major risk factor for cardiovascular disease. Investigators have also reported on the obesity paradox concept suggesting improved prognosis in patients with obesity presenting with acute coronary syndromes.
Read More
Lay Off the Energy Drinks to Maintain Blood Pressure Levels
March 13th 2015With a steady rise in energy drink consumption, especially among young adults, several medical studies have connected it to accentuated blood pressure response among caffeine-naïve adults, compared to regular caffeine users.
Read More
Comprehensive Health Model Provides Prediabetes Reversal
March 13th 2015A recent Centers for Disease Control and Prevention (CDC) study revealed 86 million Americans suffer from prediabetes, a modifiable risk factor for cardiovascular disease (CVD), and nearly half of prediabetic patients were reported to develop frank diabetes.
Read More
Impact of Medication Adherence on Diabetic Patients
March 13th 2015Chronic illness treatment typically involves some level of long-term use of pharmacotherapy. While these medications may prove efficacious in contesting the disease, their full benefits often go unmet, because nearly 50% of patients do not to take the medications as prescribed.
Read More
New Test to Aid Melanoma Diagnosis: Ready for Clinical Use?
March 11th 2015myPath Melanoma, a new 23-gene signature test fromMyriad Genetics, could potentially differentiate between malignant melanoma and benign skin moles in nearly 15% of cases where histopathologic analysis is not considered straightforward.
Read More